In the spring of 1933, in the suburbs of Sofia, the beginning of Bulgarian pharmaceutical manufacture was initiated with the building of the first manufacturing laboratory for pharmaceuticals. This was also the beginning of Sopharma, one of the most successful Bulgarian enterprises of all times. Irrespective of the form of property - private cooperative, socialist state - owned, private joint - stock company, for 70 years now Sopharma continues to be an embodiment of the human striving for health and humanity. This explains the fact that today as well Sopharma continues to be one of the largest manufacturers of pharmaceuticals - a warrantor of quality and reliability.
Established as a small manufacturing laboratory with the Bulgarian Pharmaceutical Cooperative Society in 1942, the company grew into Galenus Factory, the first modern pharmaceutical enterprise on the Balkan Peninsula. After its nationalization in 1953, Galenus Factory was renamed to Chemical - Pharmaceutical Plant. After the successful privatization in September 2000, Sopharma has become a private pharmaceutical company with priorities aimed at the establishment of the world standards for quality and efficiency.
The price of Sopharma's shares reached BGN 4.62 in 2004, which was an annual growth of 43.92 %. Only two months later, by 01 March 2005, the average daily price of the shares was BGN 7.14 per share. The stable upward trend proves that the company has answered the market expectations with respect to its financial results and corporate management, conforming this way the investors' trust.
Sopharma Trading JSCo (part of the group Sopharma) is now a leading distributor of pharmaceuticals and medicinal products, sanitary, cosmetics and food supplements. Company's has 19.7% market share for the first two months of 2007. The company is certified according ISO 9001:2000 for medicines distribution in compliance with the guidelines for Good Distribution Practices. Under the conditions of urgent investment engagements related mainly to the GMP standardization, Sopharma managed not only to satisfy, but also to increase the demand of its products. Among the best sold medicines in 2004 are Analgin, Tabex, Carsil, Sophanax and other medicines both original and generic.
In 2004 a socially significant advertising campaign for Tabex was started aimed at proving the efficacy of the product for overcoming the nicotine dependence. At the same time new products of Sopharma are launched on the market: Solipril (Lisinopril), Meloxicam (Movix), Pravastatin (Pravapres), Moclomid (Moclobemide), Metformin (Sophamet), Infludex, Hexisept, Paroxat, Tramalgin, Rytmocard.
In March 2004 the first joint project of Sopharma and GlaxoSmithKline for joint manufacture of the drug Paroxat was started to provide a higher availability to Bulgarian patients of a modern medicine for treatment of depression and anxiety disorders. This project is a foundation for future joint activities in the field of pulmonary and cardiovascular diseases.
In 2005 Sopharma JSCo built a new Distribution Center for the trading company - Sopharma Trading. This is a modern building with all necessary conditions for storage and distribution of drugs, according to the Good Distribution practices. The distribution center stores products from Sopharma's production as well as products of other pharmaceutical manufacturers and distributors. The distribution center is 5,200 sq.m., with 6,000 pallet locations - Back to Back (in stock area and also in rooms under special conditions - cold storage, under strong safety control for narcotic drugs and others) and a picking area with 2,500 picking locations (for packs). The warehouse stores above 9,000 items.
Sopharma Trading understood the need of implementing a solution to manage their supply chain, because the control and management of inventory, documents and personnel in distribution center of this kind is too hard without using state - of - the - art integrated software. Moreover in distribution of drugs there are specific conditions for storage and transport and also need for lot traceability and expiration dates. It's very important not only to know everything what is happening with the stock, but also to have the tools for optimization of all the procedures in the warehouse.
The pharmaceuticals industry has several issues that impact them:
Especially for Sopharma the demands were as follow:
Mantis was chosen by Sopharma Company, for the quality of the logistics services it provides and at the same time for the superiority of the LV application itself.
The proposed solution provided Sopharma with the following benefits:
Mantis helped Sopharma boost supply - chain performance to the maximum level. The consultants of Mantis with their deep knowledge of the pharmaceuticals - logistics sector transferred their best practices skills to the customer and added value on their existing business processes.
Sopharma was a challenge for Mantis and vice - versa. After the project closure date, Sopharma became another success story for Mantis and at the same time, Sopharma achieved a R.O.I. in a minimum time and effort. The people of Mantis, feel very proud for helping their customers on their business by providing them solutions with quality and added value. This is the driving force, in which Sopharma S.A. rely on.